BCM
RXII

Bridgeway Capital Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Bridgeway Capital Management’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-538,100
Closed -$1.65M – 1569
2014
Q2 		$1.65M Hold
538,100
– – 0.04% 577
2014
Q1 		$1.34M Hold
538,100
– – 0.04% 643
2013
Q4 		$2.67M Sell
538,100
-1,050
-0.2% -$5.21K 0.08% 356
2013
Q3 		$1.23M Buy
+539,150
New +$1.23M 0.04% 640

Other funds holding RXII

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Bridgeway Capital Management's RXII Position: Q3 2014 in Review

Bridgeway Capital Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2014, closing a stake of 538,100 shares — an estimated $1.65M sold.

Bridgeway Capital Management first reported a position in RXII in Q3 2013 and held it in 4 quarters. The position peaked at $2.67M in Q4 2013. 85 funds tracked by Wall St. Rank hold RXII as of Q3 2014.

  • Bridgeway Capital Management reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2014 after selling out during the quarter.
  • Bridgeway Capital Management sold 538,100 GALENA BIOPHARMA INC COM shares in Q3 2014, an estimated $1.65M.
  • Bridgeway Capital Management first reported a position in GALENA BIOPHARMA INC COM in Q3 2013 and held it in 4 quarters.
  • Bridgeway Capital Management's GALENA BIOPHARMA INC COM position peaked at $2.67M in Q4 2013.
  • 85 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2014.

Based on Bridgeway Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.